文献速递功能神经外科

靶点深度对磁共振引导聚焦超声丘脑毁损术治疗震颤患者安全性与疗效结局的影响

Impact of target depth on safety and efficacy outcomes in MR-guided focused ultrasound thalamotomy for tremor patients.
PubMed 文献 · J Neurosurg · 2023-11-03

该回顾性研究纳入52例药物难治性震颤患者,均接受单侧磁共振引导聚焦超声(MRgFUS)丘脑腹中间核毁损术,比较z=+2 mm组(n=17)与z=0 mm组(n=35)的疗效与安全性。结果显示z=+2 mm与6个月时任何持续性副作用发生率更高相关(p=0.02),感觉障碍在+2 mm组更常见(35% vs 11%,p=0.007),两组震颤抑制程度相似(63.6% vs 60.2%)。作者认为z=0 mm似乎安全性与疗效更有利,但需前瞻性研究。

要点

  • z=+2 mm靶点与6个月任何持续性副作用发生率更高相关(p=0.02)。
  • 感觉障碍在+2 mm组较0 mm组更常见(35% vs 11%,p=0.007)。
  • 两组平均震颤抑制相似(63.6% vs 60.2%),87%患者愿意再次接受MRgFUS。

核心结论

  • 与更背侧的z=+2 mm靶点相比,更腹侧的z=0 mm靶点似乎与更有利的安全性和相当的疗效相关,但需前瞻性研究。

研究设计与样本

  • 回顾性分析2017年至2022年间由一位神经外科医生首次实施单侧MRgFUS丘脑腹中间核毁损术的52例药物难治性震颤患者,z=+2 mm组17例、z=0 mm组35例,其余参数相同。
  • 采用标准化视频记录的评估,包括Washington Heights-Inwood Genetic Study of Essential Tremor量表(疗效)和标准化分级系统(安全性),在基线和治疗后6个月进行比较。

主要发现

  • 多因素logistic回归分析显示,与z=0 mm相比,更背侧的z=+2 mm靶点与6个月时任何持续性副作用发生率更高相关(p=0.02)。
  • 感觉障碍在+2 mm组较0 mm组更常见(35% vs 11%,p=0.007);步态障碍(29% vs 35%)和上肢共济失调(24% vs 11%)无显著差异。
  • 两组平均震颤抑制相似(63.6% vs 60.2%);在0 mm组中疗效更高与副作用负担更高相关,而在+2 mm组中无此关联。
  • 尽管出现副作用,总体患者满意度较高,87%愿意再次接受MRgFUS,多数患者更看重震颤抑制。

临床怎么用

  • 作者认为更腹侧的z=0 mm靶点似乎与更有利的安全性和相当的疗效相关,但需前瞻性研究。

局限性

  • 原文为回顾性分析。
  • 需前瞻性研究(prospective studies are warranted)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Target depth, defined by the z-coordinate in the dorsoventral axis relative to the anterior commissure-posterior commissure axial plane of the MR-guided focused ultrasound (MRgFUS) lesion, is considered to be critical for tremor improvement and the occurrence of side effects such as gait impairment. However, although different z-coordinates are used in the literature, there are no comparative studies available with information on optimal lesion placement. This study aimed to compare two different MRgFUS lesion targets (z = +2 mm vs z = 0 mm) regarding efficacy and safety outcomes. METHODS: The authors conducted a retrospective analysis of 52 patients with pharmacoresistant tremor disorders who received unilateral MRgFUS thalamotomy in the ventral intermediate nucleus for the first time between 2017 and 2022 by one neurosurgeon, with two different z-coordinates, either z = +2 mm (+2-mm group; n = 17) or z = 0 mm (0-mm group; n = 35), but otherwise identical parameters. Standardized video-recorded assessments of efficacy (including the Washington Heights-Inwood Genetic Study of Essential Tremor scale) and safety (using a standardized grading system) outcomes at baseline and at 6 months posttreatment were reviewed and compared. Moreover, overall patient satisfaction was extracted as documented by the examiner at 6 months. RESULTS: Based on a multiple logistic regression analysis, the authors found that a more dorsal target with a z-coordinate of +2 mm as compared with 0 mm was associated with a higher incidence of any persistent side effect at 6 months (p = 0.02). Most consistently, sensory disturbances, although mild and nondisturbing in most cases, occurred more frequently in the +2-mm group (35% vs 11%, p = 0.007), while no significant differences were found for gait impairment (29% vs 35%) and arm ataxia (24% vs 11%). On the other hand, average tremor suppression was similar (63.6% vs 60.2%) between the groups. Here, higher efficacy was associated with a higher side effect burden in the 0-mm group but not in the +2-mm group. Despite the occurrence of side effects, general patient satisfaction was high (87% would undergo MRgFUS again) as most patients valued tremor suppression more. CONCLUSIONS: A more ventral MRgFUS target of z = 0 mm seems to be associated with a more favorable safety and a comparable efficacy profile as compared with a more dorsal target of z = +2 mm, but prospective studies are warranted.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Büchele F, Mahendran S, Uhl M, et al. Impact of target depth on safety and efficacy outcomes in MR-guided focused ultrasound thalamotomy for tremor patients. J Neurosurg. 2023. PMID: 37922562. doi:10.3171/2023.8.JNS23472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。